← Browse by Condition
Medical Condition
relapse
Total Trials
6
Recruiting Now
6
Trial Phases
Phase 4, Phase 2, Phase 1
NCT05461820 Phase 4
Recruiting
Effects of Different Treatment Schemes on the Regulation and Recurrence of Graves' Disease
Enrollment
240 pts
Location
China
Sponsor
The First Affiliated Hospital ...
NCT06356883 Phase 2
Recruiting
Intraarterial Carboplatin + Caelyx vs Intraarterial Carboplatin + Etoposide Phosphate for Progressing Glioblastoma
Enrollment
120 pts
Location
Canada
Sponsor
Université de Sherbrooke
NCT06919939 Phase 2
Recruiting
Epcoritamab in Combination With Loncastuximab Tesirine in Relapsed/Refractory Large B-cell Lymphoma
Enrollment
26 pts
Location
United States
Sponsor
University of Miami
NCT06737523 Phase 1
Recruiting
Chiglitazar Sodium Combined With Venetoclax and Azacitidine (CVA) for the Treatment of R/R AML
Enrollment
30 pts
Location
China
Sponsor
The First Affiliated Hospital ...
NCT07105579 Phase 2
Recruiting
Effectiveness and Safety of Blinatumomab and Donor Lymphocyte Infusion in Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Transplantation for High-risk Ph Negative B Cell Acute Lymphoblastic Leukemia
Enrollment
31 pts
Location
China
Sponsor
First Affiliated Hospital of Z...
NCT06158139 Phase 1
Recruiting
Autologous CAR-T Cells Targeting B7-H3 in PDAC
Enrollment
27 pts
Location
United States
Sponsor
UNC Lineberger Comprehensive C...